- Female Alopecia18:34Paper Chase #1 - Partial Oral versus IV Antibiotic Treatment of Endocarditis6:09Asymptomatic Hypertension: ED or No ED?Free Chapter17:25Personality Disorders Part 1: Tricks of the Trade21:17Paper Chase #2 - Telemedical Management of Heart Failure5:49Eosinophilia15:18Paper Chase #3 - Thyroid Hormone Therapy on QOL in Subclinical Hypothyroidism5:42Personality Disorders Part 2: Don't Die, and Document18:22It's the System: Organizational Strategies for Burnout20:17Paper Chase #4 - Statins for Primary CV Prevention4:05DOAC Reversal20:52Starting OCPs18:05Paper Chase #5 - Evaluating Galcanezumab for the Prevention of Episodic Migraine4:27Polymyalgia Rheumatica12:30The Summary11:22
Paper Chase #5 - Evaluating Galcanezumab for the Prevention of Episodic Migraine
No me gusta!
The flash player was unable to start. If you have a flash blocker then try unblocking the flash content - it should be visible below.
BOTTOM LINE: Galcanezumab monthly injections provided clinical benefits and improved functioning in terms of reduced headache days per month, reduced use of acute migraine meds and improved patient symptom scores, with low incidence of adverse effects.